|Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe|
Providing the latest business, scientific, and regulatory news for the pharmaceutical and biotech industries.
News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts.
Industry Briefs: September 10, 2012
Boehringer Ingelheim has implemented a a flexible set-up and operational approach for disposable technologies within its biopharmaceutical development and manufacturing network. Read More
CSL Biotherapies has been awarded a contract by the US Department of Health and Human Services to supply prepandemic and pandemic vaccine antigens and related services to the US national stockpile. Read More
ICON has expanded its US and United Kingdom bioanalytical facilities to supply biomarker and cell-based assay services. Read More
MedImmune and WuXi AppTec have formed a joint venture to develop and commercialize MEDI5117, a novel biologic for autoimmune and inflammatory diseases, in China. Read More
Patheon has sold its global secondary clinical packaging and clinical distribution services business to Bellwyck Packaging Solutions, a priovider of clinical-trial and contract services for secondary packaging. Read More
FDA has approved Pfizer’s Bosulif (bosutinib), new molecular entity for treating chronic myelogenous leukemia. Read More
Sigma-Aldrich and AB SCIEX, a manufacturer of mass spectrometry instruments, have agreed to globally distribute AB SCIEX’s mass spectrometry-based tagging chemistries, called SCIEX iChemistry Solutions, for applications in basic research and applied markets. Read More
Aceto has announced that Albert Eilender will step down from his position as CEO, effective Jan. 2, 2013. He will remain as chairman of the board of directors. Salvatore Guccione has been elected to succeed Eilender as CEO, also effective Jan. 2, 2013. Read More
AMRI has appointed Daniel Conlon as senior director of business development. Read More
SciClone Pharmaceuticals has announced announced that Mark Lotter will resign from the position of CEO of the company’s China operations division at the end of 2012. A replacement candidate has not been announced. Read More